Skip to main content
. Author manuscript; available in PMC: 2014 Nov 4.
Published in final edited form as: Vaccine. 2013 Sep 13;31(46):10.1016/j.vaccine.2013.09.001. doi: 10.1016/j.vaccine.2013.09.001

Figure 1.

Figure 1

HAI titer responses of subjects. (A) The percent of patients able to demonstrate at least a four-fold rise in titer to any one of the three influenza strains after vaccination. (B) H1N1 titers across all time points do not vary dramatically. (C) The percentage of the entire cohort with baseline titers ≥1:40. OVCA=ovarian cancer patients off protocol, DC-C=dendritic cell vaccine recipients with Cytoxan, DC-NC-dendritic cell vaccine recipients without Cytoxan.